European Vitreoretinal Society Macular Hole Study, Prognostic Factors for Anatomical and Functional Success by Parolini, Barbara et al.
 
 
Med Hypothesis Discov Innov Ophthalmol. 2020; 9(3)  
 
            Medical Hypothesis, Discovery &Innovation 
Ophthalmology Journal 
 
 
  
European Vitreoretinal Society Macular Hole Study, Prognostic 
Factors for Anatomical and Functional Success 
Barbara Parolini 1, Zofia Michalewska 2, Joshua S Hardin 3, Didier Ducournau 4, Ihab Saad Othman 5, Mohammed F. Faramawi 6, 
Ron A. Adelman 7, Ahmed B. Sallam 3  
1 Istituto Clinico S.Anna di Brescia, Italy 
2 Ophthalmic Clinic "Jasne Blonia", Rojna, Poland 
3 Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA 
4 Clinique Sourdille, Nantes, France. 
5 Ophthalmology Department, Cairo University, Egypt 
6 Epidemiology Department, College of Public Health and Biomedical informatics, College of Medicine, University of Arkansas for Medical 
Sciences, Little Rock, Arkansas, USA 
7 Ophthalmology Department, Yale University School of Medicine, New Haven, CT, USA 
 
Epub: June 20, 2020  
ABSTRACT 
Background: To identify prognostic preoperative and intraoperative factors for anatomical and visual success of idiopathic 
macular hole (MH) surgery. 
Methods: We conducted a non-randomized, collaborative multicenter study using data of 4207 MH surgery from 140 
surgeons. Main study outcomes were anatomical closure and best corrected visual acuity (BCVA) improvement 
postoperative at 6-12 months.  
Results: Information on anatomical success was available for 4138 eyes of 4207 operations. Anatomical closure of MH was 
achieved in 85.7% (3546 eyes). Closure was higher in smaller MH (stages 1-2 versus stage 3: OR=0.35; stage 2 versus stage 4: 
OR=0.16, and in MH with shorter duration before the operation (OR=0.94). Macular Holes were more likely to close when dyes 
were used to facilitate internal limiting membrane (ILM) peeling (odds ratio=1.73 to 3.58). The most important predictors of 
postoperative BCVA were the preoperative BCVA (estimate=0.39, p<0.001) and closure of the macular hole (estimate=0.34, 
p<0.001). We observed Larger improvement in BCVA in combined vitrectomy and phacoemulsification (estimate = 0.10) and post 
cataract surgery in phakic eyes (estimate=0.05). Retinal tears occurred in 5.1% of eyes, and were less with use of trocars (OR= -
1.246) and in combined vitrectomy/ phacoemulsification surgery (OR= -0.688). 
Conclusion: This international survey confirmed that staining with dyes improves anatomical results but not visual 
outcomes. After surgery, visual acuity improved during the first year, and final visual acuity was better in both 
pseudophakic eyes and eyes that underwent cataract surgery during the first year following MH repair. 
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Macular Hole; Vitrectomy; Inverted ILM Flap; Full-Thickness Macular Hole; ILM Peeling; Complete Vitrectomy; Combined 
Surgery; Positioning; Internal Limiting Membrane. 
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INTRODUCTION 
Idiopathic macular hole represents a common vitreoretinal 
pathology with an estimated population-incidence of 
approximately 9 cases annually [1]. While non-surgical 
modalities including intravitreal injection of ocriplasmin or gas 
are available for the treatment of macular hole (MH) [2, 3], 
surgical treatment with pars plana vitrectomy (PPV) has 
remained the main standard approach. Pars plana vitrectomy 
in MH  surgery was first reported by Kelly and Wendel in 1991 
[4]. Their initial success rate was 58%. Since then, surgical 
techniques have been refined and results from randomized 
controlled trials [5, 6] and contemporary real world studies 
reported an anatomical closure rate of 85% or more, and visual 
improvement of approximately 2-3 Snellen line [7-10].  
Large macular holes are associated with worse visual prognosis 
and postoperative photoreceptor status has a confirmed 
correlation with visual acuity [11, 12]. However, there is 
paucity of evidence regarding the influence of intraoperative 
details on the results of MH surgery. Specifically, the role of 
intraocular tamponades [10, 13, 14], internal limiting 
membrane (ILM) peeling [15-20], ILM staining and the 
influence of the types of staining dye [21], and postoperative 
positioning [22-29] are still frequently debated. The main 
conclusion derived from a review of the literature is that meta-
analyses and well-conducted, controlled trials are necessary to 
determine which surgical details are prognostic in MH surgery 
[30, 31]. Given the differences in the reporting outcomes in 
each study, and the varying surgical details, a meta-analysis 
would hardly be possible. A randomized clinical trial on a 
sufficiently large group of patients would also be costly, time 
consuming and may not reflect routine clinical care.  
The European VitreoRetinal Society (EVRS) has previously 
conducted large studies  examining the treatment of retinal 
detachment and macular edema in the real-world setting [32-
37]. In the current investigation, a total of 4,207 operations for 
idiopathic MH performed by 140 surgeons from 28 countries 
were evaluated.  
We aimed to report anatomical and functional outcomes of 
surgery for MH and to analyze the influence of different pre-, 
intra-operative factors. While one larger study has reviewed 
reoperation and retinal detachment with MH surgery [20], to 
our knowledge this is the largest comprehensive report on the 
anatomical and visual outcomes of MH in the literature to 
date. 
METHODS 
The EVRS Macular Hole Study is a non-randomized, multi-
center retrospective survey designed to identify pre-, intra-, 
and post-operative factors determining anatomical and 
functional success of MH repair. Macular hole operations 
reported between June 2008 and June 2012 by the society 
members were included. In total, 4,207 macular holes were 
operated by 140 vitreoretinal specialists from 28 countries 
across 4 continents (Figure 1 and 2 represent surgeons and 
eyes break down by country). The data gathered included lens 
status, hole duration, gauge, the use of trocars, suturing of 
scleral wounds, combined procedures, posterior hyaloid 
removal, internal limiting membrane (ILM) staining, ILM 
peeling, type of tamponade, completeness of tamponade, 
details of postoperative positioning, cataract formation, and 
complications including retinal tear and detachment (Table 1). 
The anatomical outcomes of repair were classified as follows; 
macular hole closed with edges not visible; hole open with 
edges visible and attached hole open with edges elevated; hole 
open with edges visible and attached. Only cases with macular 
hole closed and edges not visible were accounted as 
anatomical successes. Follow-up periods were 3-6 months, 6-
12 months and 12+ (12-15) months after surgery. 
To identify the most relevant predictors for best corrected 
visual acuity (BCVA) at three postoperative follow-up periods, 
a linear mixed effects model with two nested random effects 
was considered [38].  The model involved considering a 
surgeon’s (or group of surgeons’) random effect to account for 
surgeon heterogeneity and a patient’s random effect nested 
within the surgeon’s random effect to account for patient 
heterogeneity.  
The considered potential predictors for BCVA were 
preoperative BCVA at different follow-up visits, stage, size 
(small, medium, large), hole duration, lens status, anatomical 
success, vitrectomy completeness (core, subtotal, complete), 
gauge, trocar, suturing of scleral wounds, combined 
phacoemulsification, type of dye, extent of posterior hyaloid 
removal (limited to the posterior pole or large), quality of 
tamponade, type of tamponade (complete versus 
incomplete), concentration of gas, quality of postoperative 
positioning (either strict prone positioning or patients advised 
not to look up, or no positioning at all), and duration of 
postoperative positioning. The model was estimated by the 
maximum likelihood method through the lme function in R 
package [39] nlme [40]. Please define yellow colors 
The predictors of the probability of anatomical success 
were evaluated through a multivariate logistic model with 
a random intercept to account for surgeon heterogeneity. 
The considered potential predictors for anatomical 
success were MH stage, hole duration, crystalline lens 
status, vitrectomy completeness, combined 
phacoemulsification, type of dye to stain ILM, posterior 
hyaloid removal, quality of tamponade, type of 
tamponade, concentration of gas, quality of postoperative 
positioning and duration of postoperative positioning. The 
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model was estimated by the maximum likelihood method 
through R package glmmML [41]. For all multivariate 
regression analyses, model selection was based on the 
stepwise method with Akaike Information Criterion [42]. 
 
 
 
Figure 1. Number of Surgeons by Country.   
 
 
 
 
 
      
Figure 2. Number of Operations by Country. 
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Table 1. Variables That Surgeons Were Asked to Report to Assess Anatomical and Visual Outcome of MH Surgery 
Clinical Findings  Pars Plana 
Vitrectomy 
 
Additional 
Intraoperative details  
Tamponade Anatomical and Visual 
Outcomes  
Postoperative 
Complications 
• Stage of FTMH 
• FMTH duration 
• Pre-operative 
BCVA 
• Date of operation 
• Gauge 
• Trocar use 
• Suturing of scleral 
wounds 
• Combined 
phacoemulsificatio
n vitrectomy  
• Special techniques 
• Intraoperative 
complications 
• ILM peeling (yes/ no) 
• Dye used (none, 
trypan blue/ 
membrane blue, 
brilliant blue, 
Indocyanine green, 
other) 
• Peeling (100% sure/ 
not sure) 
• Technique of peeling 
• Complications of 
operation 
• Type of tamponade (air, SF6, 
C2F6, C3F8, silicone oil) 
• Complete (≥80%) fill/ 
Incomplete tamponade 
• Special techniques 
• Postoperative positioning 
(none, just look down, prone 
positioning) 
• Duration of postoperative 
positioning 
• FTMH closed (edges 
not visible) / flat 
edges/elevated edges 
• BCVA 3-6 months 
• BCVA 6-12 months 
• BCVA 12-15+ (12+) 
months 
• Cataract 
• Retinal tear 
• Retinal 
detachment 
• MH 
reoperation 
• Hypotony 
FTMH: full thickness macular hole; BCVA: best corrected visual acuity; ILM: internal limiting membrane; MH: macular hole 
 
Table 2. Odds Ratios With 95% Confidence Intervals (CI) in Parentheses and P-Values for the Regression Coefficients of the Selected Logistic Mixed Effects 
Model for the Probability of Anatomical Closure of Macular Hole.  
Coefficients Odds ratio (95% CI) p-value 
Stage 
Stage 3 FTMH 0.35 (0.20, 0.61) <0.001 
Stage 4 FTMH 0.16 (0.09, 0.28) <0.001 
FTMH duration  0.94 (0.91, 0.97) x 10-3  <0.001 
Type of Dye 
Brilliant blue   1.73 (1.05, 2.86) 0.031 
Indocyanine green 2.51 (1.34, 4.69) 0.004 
Trypan/Membrane blue 2.27 (1.12, 4.60) 0.023 
Other 3.58 (1.31, 9.75) 0.013 
FTMH: full thickness macular hole; P<0.05 in bold. 
 
 
 
Table 3. Estimates With 95% Confidence Intervals (CI) in Parentheses and P-Values for the Regression Coefficients of the Selected Linear Mixed Effects 
Model for BCVA Variation in Macular Hole 
Coefficients  Estimate (95% CI)  p-value 
Preoperative BCVA  0.39 (0.35, 0.43) <0.001 
6-12 months BCVA 0.09 (0.08, 0.10) <0.001 
12+ months BCVA 0.11 (0.10, 0.13) <0.001 
   MH closed  0.34 (0.31, 0.38) <0.001 
   Stage 3 MH -0.06 (-0.09, -0.02) 0.002 
   Stage 4 MH -0.11 (-0.15, -0.07) <0.001 
   MH duration  -0.78 (-1.16, -0.41) x 10-3 <0.001 
   Incomplete intraocular tamponade  0.05 (0.00, 0.10) 0.075 
   Pseudophakia  0.05 (0.02, 0.09) 0.001 
   Combined phacoemulsification, lens implantation and vitrectomy 0.10 (0.06, 0.14) <0.001 
   Duration of postoperative positioning  -0.11 (-0.18, -0.04) x 10-1 0.002 
BCVA: best corrected visual acuity; MH: macular hole; P<0.05 in bold. 
 
 
Table 4. Odds Ratios With 95% Confidence Intervals (CI) in Parentheses and P-Values for the Regression Coefficients of The Selected Logistic Mixed Effects 
Model for the Probability of Successive Cataract Surgery following Macular Hole Surgery. P<0.05 in bold. 
Coefficients   Odds ratio (95% CI) p-value 
Transconjunctival vitrectomy  0.43 (0.26, 0.72) 0.001 
Gas dilution  1.18 (1.02, 1.36) x 10-1 0.023 
C3F8 gas versus C2F6 gas 2.02 (1.04, 3.92) 0.038 
 SF6 gas versus C2F6 gas 1.42 (0.75, 2.68) 0.277 
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Figure 3. Postoperative Visual Acuity Lines Gained as a Function of Preoperative Vision in Logarithm of the Minimum Angle of Resolution (LogMAR) With 
95% Confidence Intervals for Average Levels. 3-6 months: 3-6 months Postoperation; 6-12 months: 6-12 months Postoperation; 12+ months: 12-15 Months 
Postoperation.  
 
RESULTS  
Preoperative characteristics  
Information on stage of MH was available for 3633 of 4207 
(86.4%) eyes. Stage 1 MH was observed in 149 eyes (4.1% 
of cases with information about stage), stage 2 in 661 eyes 
(18.2%), stage 3 in 1294 eyes (35.6%) and stage 4 in 1529 
eyes (42.1%). Stages 1 and 2 were merged since the 
frequency of stage 1 holes was considered low for reliable 
statistical analysis. Information about lens status was 
available for all but seven eyes. At the time of surgery, 
0.4% (15 eyes) of patients were aphakic, 26.2% (1,100 
eyes) were pseudophakic and 73.5% (3,085 eyes) phakic. 
Combined phacoemulsification, lens implantation and 
vitrectomy surgery were performed in 25% of initially 
phakic eyes. 
 
Anatomical Results 
Information on anatomical success was available for 4138 
of 4207 eyes. Overall anatomical success rate, defined as 
complete closure with edges not visible, was 85.7% (3546 
eyes). Anatomical failure, with flat open MH was observed 
in 7.7% (318 eyes) of cases, and with elevated edges in 
6.6% (274 eyes). The selected logistic mixed model for 
anatomical success is summarized in Table 2. Anatomical 
success was higher in smaller macular holes (stages 1-2 
versus stage 3: odds ratio=0.35, p=0.001; stage 2 versus 
stage 4: odds ratio=0.16, p<0.001) and in macular holes 
with shorter durations before the operation (odds 
ratio=0.94, p<0.001). When eyes with stage 2 macular 
holes were analyzed separately, the results were similar to 
those of the group including stages 1 and 2. Macular Holes 
were more likely to close when dyes were used to 
facilitate ILM peeling (odds ratio=1.73 to 3.58), compared 
to without the use of dyes; however, there were no 
statistically significant differences between various types 
of dyes (Indocyanine Green, Trypan/Membrane blue and 
Brilliant blue). 
 
Visual Acuity Results 
Figure 3 displays the visual acuity lines gained as a function 
of preoperative Logarithm of the Minimum Angle of 
Resolution (LogMAR) VA. Improvement in postoperative 
BCVA was statistically significant at all successive follow-
up intervals (3-6 months versus 6-12: estimate=0.09, 
p<0.001; 3-6 versus 12+: estimate=0.11, p<0.001). The 
selected linear mixed model for BCVA variation is 
summarized in Table 3. The most important predictors of 
postoperative BCVA were the preoperative BCVA 
(estimate=0.39, p<0.001) and postoperative closure of the 
macular hole (estimate=0.34, p<0.001).  
Postoperative BCVA was inversely associated with the 
duration of symptoms (estimate =-0.78x10-3, p<0.001) and 
the stage of hole at the time of operation (stage 2 versus 
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stage 3: estimate =-0.06, p=0.002, stage 2 versus stage 4: 
estimate=-0.11, p<0.001). The role of ILM peeling on 
functional and anatomical results could not be evaluated, 
as most (95.7%) surgeons peeled the ILM. The effect of 
incomplete versus complete tamponade on BCVA was not 
significant (estimate =0.05, p=0.075) and the effect of 
postoperative positioning on BCVA was negatively related 
to its duration (estimate =-0.11x10-1, p=0.002). 
An improvement in BCVA was observed for combined 
vitrectomy and phacoemulsification (estimate =0.10, 
p<0.001) as well as after cataract surgery regarding phakic 
eyes (estimate=0.05, p=0.001). The average number of 
logMAR lines gained after 12 months was 4.1 ± 4.09 lines 
for eyes undergoing combined surgery and 4.41 ± 3.62 for 
those who subsequently underwent cataract surgery and 
was not different (p=0.168). 
Special Techniques 
The inverted ILM flap technique was used in a small 
sample of eyes: 238 eyes (5.6%), predominantly in stage 4 
macular holes (13 % of stage 4 macular holes were 
operated using ILM flap). Better anatomical and visual 
outcomes were noted regarding macular hole closures 
(odds ratio=14.45, p<0.001) and BCVA (estimate =1.42 
x10-1, p=0.049) when this technique was used compared 
to ILM peel in this subset of eyes.  
Complications 
Of 3085 initially phakic eyes, 1095 (35.5%) underwent 
subsequent cataract surgery. Survival time analysis 
showed that the median time for cataract surgery was 8 
months and that only 26.4% were operated within the first 
month following vitrectomy. Risk factors analysis 
confirmed that both the use of transconjunctival 
vitrectomy with trocars (odds ratio=0.43, p=0.001) and 
tamponades with lower gas concentrations (odds 
ratio=1.18, p=0.023 for concentration of gas x10-1) were 
negatively associated with cataract surgery (Table 4). 
However, the use of C3F8 was more highly associated with 
cataract surgery than C2F6 (odds ratio=2.02, p=0.038), 
while there was no difference in the odds of cataract 
surgery comparing SF6 and C2F6 (odds ratio=1.42, 
p=0.277). 
Regarding other complications, repeated surgery was 
performed in 24.3% of eyes with postoperative elevated 
edges, the results of which were not recorded. Retinal 
tears occurred in 5.1% of cases. The logistic mixed effects 
model for the probability of retinal tears indicated that 
use of trocars (odds ratio= -1.246, p- value=<0.001) and 
combining surgery with cataract (odds ratio= -0.688, p-
value=0.004) were associated with a lower risk of retinal 
tears. Subsequent rhegmatogenous retinal detachment 
occurred in 3.6% of cases. Transient postoperative 
hypotony was observed in ten eyes, which was too low for 
statistical analysis. In these cases, no scleral sutures were 
used.  
 
DISCUSSION 
Surgery for macular hole is a commonly performed 
vitreoretinal operation with usually favorable outcomes 
[43]. Accordingly, there is a considerable clinical interest 
in the outcome of surgery, and the success rate for 
macular hole repair is often used as an indicator for 
evaluating vitreoretinal surgeons’ performance. It is 
therefore important to present large outcome data from 
different surgeons to benchmark against, and to analyze 
the factors influencing the functional and anatomical 
outcomes for MH surgery. Herein, we presented the 
results of 4207 eyes with MH surgery from 140 surgeons, 
the largest comprehensive report to date. 
While one recent retrospective study reported no 
difference in outcomes based on the duration of 
symptoms [44], this study confirmed the findings of earlier 
studies indicating that anatomical and functional 
successes are more often achieved in smaller macular 
holes with shorter durations and those with better 
preoperative visual acuity [45-47]. The duration of 
symptoms is a subjective parameter and should be 
interpreted cautiously. We also found that visual acuity 
improves during the first 12 months of surgery. This is also 
true for stage IV, chronic macular holes, and may be 
explained by restoration of foveal contour and the 
ellipsoid zone continuity [48]. 
We found that almost a half of patients underwent 
phacoemulsification during the study period. Better final 
BCVA was achieved in pseudophakic eyes and in those 
who underwent subsequent cataract surgery. However, in 
our study, timing of cataract surgery (simultaneous versus 
delayed) had no influence on the final 12-months 
outcome, which was previously observed in a small 
retrospective analysis [10].  
One recent study showed that improvement with 
phacoemulsification after MH surgery is associated with 
better vision-related quality of life and recommended 
combined surgery [49]. Thus, it may be reasonable to 
schedule patients for phacoemulsification soon after 
vitrectomy for MH to offer a prompt improvement in 
vision.  
Regarding tamponades, the type and dilution of gas did 
not significantly impact the anatomical or functional 
results. This in line with a recent meta-analysis that looked 
at the outcome of macular hole surgery operated with SF6 
versus C3F8 gas [14], however, a large retrospective 
registry study indicated better vision in eyes operated 
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with short acting gas [10]. Recent studies have also 
continued to debate postoperative positioning [29, 50, 
51], with one recent meta-analysis supported the use of 
face down positioning [28]. In this series, we observed 
worse functional results in patients who were advised 
longer periods of postoperative positioning. It might be 
because surgeons might have advised strict positioning in 
more complex cases. Thus, it may be reasonable to use 
shorter-acting gases such as SF6 and shorter positioning 
to reduce patient discomfort, improve adherence, and 
enable earlier airplane travel. However, as this study was 
not randomized, the data on positioning should be 
interpreted with caution. 
Peeling of the ILM has been shown to be associated with 
improved anatomical success, however, its influence on 
visual success remains unclear. Data from a recent 
registry-based study from the New Zealand and Australia 
demonstrated that while  peeling of the ILM increased the 
anatomical closure rate [10] this did not lead to better 
visual acuity outcomes at 3 or 12 months. In contrast, a 
meta-analysis of 4 randomized controlled studies 
conducted in 2014  demonstrated  that ILM peeling was 
associated with a significant albeit small (approximately 1 
LogMAR) visual improvement over no ILM peeling at 3 
months [52]. In the present study, 95.7% of surgeons 
chose to peel the ILM, thus preventing a comparison. The 
use of staining for the purpose of ILM peeling was an 
important predictive factor of anatomical, but not 
functional success. The difference between the types of 
dyes was not statistically significant.  
The inverted ILM flap technique was previously reported 
to increase the success rate in the treatment of large, 
stage 4 macular holes and macular holes associated with 
high myopia [9, 53, 54]. One recent retrospective study 
compared 300 eyes with ILM peel and 320 eyes with the 
inverted ILM flap technique and indicated a difference in 
overall success rates of 78.6% and 95.6%, respectively in 
eyes with MH≥400 [55]. We confirm the results of these 
studies, showing that this technique improves anatomical 
and functional results in large macular holes.  
We found a 5% intraoperative rate of iatrogenic retinal 
tears and risk was lower in transconjunctival vitrectomy 
with the use of trocars. The reported rates of retinal tears 
with MH surgery in the literature vary widely with some 
studies reporting figures as high as 16% [56]. Our results 
are comparable to those of a large national database 
study from the United Kingdom that reported retinal tears 
in 7% with PPV for MH.  
The results of our study need to be interpreted with 
caution because of the risk of bias associated with 
nonrandomization and its retrospective design. Similar to 
other database studies, there were missing data in our 
studies which may affect the study quality and there was 
a variation in techniques used based on surgeons’ 
preference. Considering that a large number of physicians 
for more than 20 countries participated in this study, we 
expect the effect of these biases to be small. The large 
scale of data also makes it representative of retinal 
physicians’ practice and suitable for surgeon 
benchmarking, as compared to studies originating from 
selected institutions. 
 
CONCLUSION 
This multicenter survey confirms earlier data from smaller 
studies which showed better results in low-stage, short-
term macular holes with good initial visual acuity. 
Phacoemulsification, performed before, during or after 
vitrectomy was one of the most important factors 
influencing functional results. In stage IV macular holes, 
the inverted ILM flap technique was associated with 
greater anatomical and functional success. Internal 
limiting membrane staining improved anatomical results 
without a significant difference between dyes. Moreover, 
longer positioning and use of long-acting gases or silicone 
oil were not shown to improve outcomes. A prospective 
study might add more insight on the effect of tamponade 
type and postoperative positioning on macular hole 
closure. 
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